echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Lancet Diabetes Endocrino: Analysis of the 2019 Global Burden of Disease Study: Reducing Under-25 Diabetes Mortality Remains a Major Challenge, Optimizing Insulin, Basic Diabetes Education and Care Urgently

    Lancet Diabetes Endocrino: Analysis of the 2019 Global Burden of Disease Study: Reducing Under-25 Diabetes Mortality Remains a Major Challenge, Optimizing Insulin, Basic Diabetes Education and Care Urgently

    • Last Update: 2022-04-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    In contrast, death from acute complications (ie, diabetic ketoacidosis, hyperosmolar coma, and severe hypoglycemia), premature renal failure, and acute infection can be prevented with minimal core measures


    Many low- and middle-income countries have made considerable progress in providing minimum core actions to prevent deaths from acute complications of diabetes



    The Global Burden of Disease, Injury and Risk Factors study (GBD) has attempted to develop a simple and up-to-date indicator of potentially preventable diabetes mortality using readily available GBD 2019 worldwide country data to assess diabetes deaths in people under 25 years of age.



    Socio-Demographic Index (SDI) Universal Health Coverage (UHC)

    • Globally, in 2019, 16,300 people (95% uncertainty interval, 14,200 to 18,900) died from diabetes (type 1 and type 2 combined), of which 73.


      Reducing diabetes mortality under 25 years of age remains a major challenge, especially in low and moderately low SDI countries




      leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.